Bvf Inc Elevation Oncology, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Bvf Inc holds 2,966,836 shares of ELEV stock, worth $1.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,966,836
Previous 2,966,836
-0.0%
Holding current value
$1.6 Million
Previous $1.78 Million
3.37%
% of portfolio
0.06%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ELEV
# of Institutions
71Shares Held
39.1MCall Options Held
100Put Options Held
3.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$3.24 Million0.21% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$2.57 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$1.9 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.53 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$1.41 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $12.6M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...